Administering oral vaccines and modulating gastrointestinal immunity using a new physical device

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Oral vaccination is an ideal delivery route due to its ease of administration, abundance of immune cells in the GI tract and production of protective mucosal immunity at pathogen entry sites. However, its exploitation is limited by delivery challenges such as vaccine degradation in the stomach and poor uptake across mucosa. I will develop a biomedical device which carries and directly delivers vaccines to intestinal mucosa, which ultimately has the potential to replace the needle and syringe.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2021

Funding Scheme: Early Career Fellowships

Funding Amount: $408,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biomedical Engineering not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomedical engineering | drug delivery systems | gastroenterology | immunology | vaccine technology